Synlogic therapeutics stock
WebAug 11, 2024 · 212-253-8881; [email protected]. SYNLOGIC INVESTOR CONTACT: Andrew Funderburk. Kendall Investor Relations. 617-914-0008; [email protected]. GINKGO BIOWORKS INVESTOR CONTACT: investors ... Web2 days ago · Get a real-time Synlogic, Inc. (SYBX) stock price quote with breaking news, financials, statistics, charts and more. Get a real-time ... Mass., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that SYNB1934 was granted Rare ...
Synlogic therapeutics stock
Did you know?
WebJan 31, 2024 · The story starts with a startup called Mirna Therapeutics that had raised $110 million from big name investors like New Enterprise Associates, Pfizer, and Baxter to pursue an RNAi drug development platform they had been working on since 2007.In October of 2015, Mirna had an IPO which has since lost more than -80% of its value. Mirna was a … WebDec 31, 2024 · Synlogic is the leading company advancing therapeutics based on synthetic biology. Synlogic’s pipeline includes its lead program in phenylketonuria (PKU), which has …
WebMay 16, 2024 · MEDIA: Synlogic Courtney Heath, 617-872-2462 [email protected] or Mirna Therapeutics Brad Miles, 646-513-3125 [email protected] or INVESTORS: Synlogic Christina Tartaglia, 212-362 ... WebJan 19, 2024 · Continue Reading. October 18, 2024. Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3. Continue …
WebMar 7, 2024 · News Releases. Synlogic Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates. Synlogic Receives Positive Opinion on Orphan …
WebName. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and …
WebApr 12, 2024 · The global Microbiome Therapeutics market size is projected to reach USD 892.2 million by 2028, from USD 91 million in 2024, at a CAGR of 38.1Percent during 2024-2028. The Application of ... dr heyraud christopheWebMar 28, 2024 · Synlogic is the leading company advancing therapeutics based on synthetic biology. Synlogic’s pipeline includes its lead program in phenylketonuria (PKU), which has demonstrated proof of concept with plans to start a pivotal, Phase 3 study in the first half of 2024, and additional novel drug candidates designed to treat homocystinuria (HCU), … dr. heyoung mcbride nmWebMr. Jensen was formerly the CFO of Intrinsic Therapeutics. Fourth Quarter 2024 Financial Results. As of December 31, 2024, Synlogic had cash, cash equivalents, and marketable … dr hey raleigh ncWeb1 day ago · Synlogic Therapeutics. Investor Relations. IR menu. Overview; News. News Releases In the News. ... Stock Quote & Chart ... Synlogic. 301 Binney St #402 Cambridge, … entry level jobs downtown chicagoWebSynlogic GAAP EPS of -$0.24 beats by $0.02, revenue of $0.11M misses by $0.12M (NASDAQ:SYBX) Benzinga. 1 week ago. Synlogic Reports Fourth Quarter and Full Year … dr hey raleighWebMay 16, 2024 · Upon closing, Synlogic security holders are expected to own approximately 83.18% of the outstanding shares of MIRN common stock on a fully- diluted basis and security holders of MIRN as of immediately prior to the merger are expected to own approximately 16.82% of the outstanding shares of MIRN common stock. entry level jobs for anthropology majorsWebMar 17, 2024 · Entity Common Stock, Shares Outstanding : 70,228,487 : Entity Public Float : $ 122.2: Title of 12(b) Security: Common Stock, par value $0.001 per share : Entity File Number: 001-37566 : Entity Incorporation, State or Country Code: DE : Entity Tax Identification Number: 26-1824804 : Entity Interactive Data Current: Yes : Security … dr heyrani temecula